Enhancing Patient Care in PPF: Strategies for Addressing Unmet Needs and Optimizing Treatment Approaches : Episode 6

Emerging Therapies for PPF

January 28, 2025

By Anna-Maria Hoffmann-Vold, M.D., Ph.D.

Opinion

Video

Panelists provide an overview of emerging therapies for progressive pulmonary fibrosis (PPF), highlighting the latest developments and potential treatment options.

EP: 1.Understanding PPF and Its Risk Factors

EP: 2.PPF Symptoms and Impact on Quality of Life

EP: 3.Diagnosing PPF and the Importance of Early Detection

EP: 4.Current Treatment Approaches for PPF: Pharmacological and Nonpharmacological

EP: 5.Key Unmet Needs in PPF Management

Now Viewing

EP: 6.Emerging Therapies for PPF

EP: 7.Potential Impact of Emerging PPF Treatments on Patient Outcomes and Health Ccare Resource Utilization

Video content above is prompted by the following:

Please provide an overview of the emerging therapies for PPF.

Related Content

Value-Based Decision-Making in Metastatic Breast Cancer

Ian E. Krop, MD, PhD;Debra Patt, MD, PhD, MBA

September 16th 2021

Article

In this Managed Healthcare Executive® KCast, Ian Krop, M.D., Ph.D., oncologist and associate professor of medicine at Dana-Farber Cancer Institute in Boston, and Debra Patt, M.D., Ph.D., MBA, executive vice president at Texas Oncology in Austin, provide key insights into the value-based care model for patients with HER2-positive metastatic breast cancer (mBC). This article summarizes the highlights of the discussion.